Expression of the p53 homologue p63α and ΔNp63α in the neoplastic sequence of Barrett's oesophagus:: correlation with morphology and p53 protein

被引:24
|
作者
Hall, PA
Woodman, AC
Campbell, SJ
Shepherd, NA
机构
[1] Gloucestershire Royal Hosp, Dept Histopathol, Gloucester GL1 3NN, England
[2] Gloucestershire Royal Hosp, Sch Gloucestershire, Cranfield Postgrad Med Sch, Gloucester GL1 3NN, England
[3] Cranfield Univ, Cranfield BioMed Ctr, Cranfield MK43 0AL, Beds, England
[4] Univ Dundee, Dept Mol & Cellular Pathol, Dundee DD1 9SY, Scotland
关键词
p53; p63; immunohistochemistry; Barrett's oesophagus; dysplasia; adenocarcinoma;
D O I
10.1136/gut.49.5.618
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background-While loss of p53 function is a key oncogenic step in human tumorigenesis, mutations of p53 are generally viewed as late events in the metaplasiadysplasia-adenocarcinoma sequence of Barrett's oesophagus. Recent reports of a series of genes (p63, p73, and others) exhibiting close homology to p53 raise the possibility that abnormalities of these p53 family members may exert their influence earlier in the sequence. Aim-Following recent characterisation of expression of p63 and a major isoform Delta Np63 by generation of an antiserum. that recognises p63 isoforms, but not p53, our aim, was a comparative study of expression of p63 protein and p53 protein in a morphologically well defined biopsy series representative of all stages of the metaplasia-dysplasia-carcinoma sequence in Barrett's oesophagus. Methods-A series of 60 biopsy cases representing normal oesophagus through to invasive adenocarcinoma were stained, using immunohistochemistry, with antibodies to p63 and p53. All biopsies derived from patients with endoscopic and histopathological substantiation of a diagnosis. of traditional/classical Barrett's oesophagus. Results-There was exact concordance in p53 and p63 expression in more advanced forms of neoplasia, high grade dysplasia, and invasive adenocarcinoma, while p63, but not p53, was detected in the proliferative compartment of some non-neoplastic oesophageal tissue, in both squamous mucosa and in the non-neoplastic metaplastic glandular epithelium. Conclusions-In neoplastic Barrett's oesophagus there is upregulation of both p63 and p53 while p63 isoforms may well have an important role in epithelial biology in both non-metaplastic and metaplastic mucosa of the oesophagus. While abnormalities of p53 function represent an indisputable and critical element of neoplastic transformation, other closely linked genes and their proteins have a role in both the physiology and pathophysiology of the oesophageal mucosa.
引用
收藏
页码:618 / 623
页数:8
相关论文
共 50 条
  • [21] Identification of a basal/reserve cell immunophenotype in benign and neoplastic endometrium:: A study with the p53 homologue p63
    O'Connell, JT
    Mutter, GL
    Cviko, A
    Nucci, M
    Quade, BJ
    Kozakewich, HPW
    Neffen, E
    Sun, DQ
    Yang, A
    McKeon, FD
    Crum, CP
    GYNECOLOGIC ONCOLOGY, 2001, 80 (01) : 30 - 36
  • [22] Subclassification of malignant mixed mullerian tumors (carcinosarcoma) with the p53 homologue p63
    Hirsch, MS
    Nucci, MR
    Hecht, JL
    Cviko, A
    Crum, CP
    MODERN PATHOLOGY, 2003, 16 (01) : 192A - 192A
  • [23] Differential effects of p63 mutants on transactivation of p53 and/or p63 responsive genes
    Khokhar, Shama K.
    Kommagani, Ramakrishna
    Kadakia, Madhavi P.
    CELL RESEARCH, 2008, 18 (10) : 1061 - 1073
  • [24] Differential effects of p63 mutants on transactivation of p53 and/or p63 responsive genes
    Shama K Khokhar
    Ramakrishna Kommagani
    Madhavi P Kadakia
    Cell Research, 2008, 18 : 1061 - 1073
  • [25] Subclassification of malignant mixed mullerian tumors (carcinosarcoma) with the p53 homologue p63
    Hirsch, MS
    Nucci, MR
    Hecht, JL
    Cviko, A
    Crum, CP
    LABORATORY INVESTIGATION, 2003, 83 (01) : 192A - 192A
  • [26] p51/p63, a novel p53 homologue, potentiates p53 activity and is a human cancer gene therapy candidate
    Kunisaki, Reiko
    Ikawa, Shuntaro
    Maeda, Toyoki
    Nakazaki, Yukoh
    Kurita, Ryo
    Harata, Masamitsu
    Shutoh, Yukinobu
    Bai, Yuang Sung
    Soda, Yasushi
    Tanabe, Tsuyoshi
    Dohi, Taeko
    Kato, Rie
    Ikawa, Yoji
    Asano, Shigetaka
    Tani, Kenzaburo
    JOURNAL OF GENE MEDICINE, 2006, 8 (09): : 1121 - 1130
  • [27] From p63 to p53 across p73
    Strano, S
    Rossi, M
    Fontemaggi, G
    Munarriz, E
    Soddu, S
    Sacchi, A
    Blandino, G
    FEBS LETTERS, 2001, 490 (03): : 163 - 170
  • [28] p63 and p53: Collaborative Partners or Dueling Rivals?
    Woodstock, Dana L.
    Sammons, Morgan A.
    Fischer, Martin
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [29] Mutant P53 Gain of Function Via P63
    Stindt, M.
    Muller, P.
    Vousden, K. H.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S36 - S37
  • [30] Mutant p53 alters regulation of survivin by p63
    Mishra, R.
    Mundhe, D.
    Waghole, R.
    Teni, T.
    EUROPEAN JOURNAL OF CANCER, 2016, 54 : S17 - S17